Amgen Profile

185.16
USD 0.01  0.0054%
71%
0%

Amgen exotic insider transaction detected

Amgen insider trading alert for general transaction of common stock by Frank Herringer, the corporate stakeholder, on June 22, 2018. This event was filed by Amgen Inc with SEC on 2016-05-05. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Amgen Summary

Amgen (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with current market capitalization of 123.2 B. Amgen conducts business under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 661.71 M outstanding shares of which 10.72 M shares are presently shorted by private and institutional investors with about 3.27 trading days to cover. AMGEN currently holds about 32.17 B in cash with 8.46 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 48.62.
Check Amgen Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 185.16HorizonTargetOdds Above 185.16
76.24%30 days 185.16 23.24%
Based on normal probability distribution, the odds of Amgen to move above current price in 30 days from now is about 23.24% (This Amgen probability density function shows the probability of Amgen Stock to fall within a particular range of prices over 30 days) .

Top Holders

Selected Amgen Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Amgen Against Markets

Risk Adjusted
Performance Score (0 to 100)
15 
Chance of
Financial Distress (0 to 100%)
28 
Equity ratings for Amgen are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ. It employs 20800 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAmgen
ChairmanRobert BradwayView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 5 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
RegionNorth America
LocationCALIFORNIA, U.S.A
Business AddressOne Amgen Center Drive
Foreign Associates
ExchangeNASDAQ
CIK Number00318154.0
ISINUS0311621009
CUSIP031162100
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.amgen.com
Contact Number805 447 1000
CurrencyUSD - US Dollar

Recommendations

Amgen Analyst Recommendations
Target PriceAdvice# of Analysts
183.83Hold12Odds
Amgen current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Amgen Analyst Advice  

Earnings

Amgen Earnings Estimates
EPSEstimate Date
Quarterly Estimate2.99April 27, 2017
Amgen normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

Amgen Corporate Directors
Frank Herringer Independent Director
Francois Carbonnel Independent Director
Rebecca Henderson Independent Director, Ph.D
Check also Trending Equities. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.